Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1

PLoS One. 2018 Feb 1;13(2):e0192424. doi: 10.1371/journal.pone.0192424. eCollection 2018.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0175478.].

Publication types

  • Published Erratum